AGA Committee for GI Innovation & Technology
The AGA Committee for GI Innovation and Technology (CGIT) supports innovation and the development of new technology in gastroenterology, hepatology, nutrition and obesity by guiding medical device and therapeutics innovators through the technology development and adoption process.
Get to know the committee
AGA is committed to advancing innovation in GI and putting new technology into practice. That’s why we developed the AGA Committee for GI Innovation and Technology. The committee is a key resource for industry and physician innovators developing new technology in GI, as well as FDA and other regulatory groups involved in the device approval and adoption process. The committee’s main goal is to ensure the needs of gastroenterologists and patients are met with each new technology.
Industry partners
The committee offers a wide range of services that support the development and adoption of new technologies. We make use of an extensive physician and research network with a broad spectrum of expertise to help guide companies through the GI device development process. Let’s work together to advance innovation in GI.
- Objective reimbursement assessment and recommendations
- Assessment of peer-reviewed literature
- Clinical study design and development
- Identification of experts
Contact innovation@gastro.org to learn more.
AGA and MATTER launch first-of-its-kind digestive disease incubator
AGA has partnered with Varia Ventures to launch a new fund dedicated to investing in fast-growing, early-stage companies in the GI space. The fund will speed innovations from concept to clinic for the benefit of patients with digestive disease.
Read more about this venture in the AGA press release from January 2022.
Congratulations to our innovative funding recipients
The GI Opportunity Fund is excited to announce that it has completed its first five investments. Each one of these funding recipients is developing innovative GI tech that can transform care for patients with digestive disease.
- Virgo is an AI-fueled endoscopy capture and clinical trials program.
- EndoSound developed a system to transform any endoscope into an EUS.
- NeXtGen Biologics has patent-protected technology using the tissue of a salamander with regenerative abilities for a variety of clinical benefits.
- EvoEndo has created sterile single-use, flexible endoscopes that enable unsedated endoscopic procedures.
- Oshi Health‘s innovative, virtual care delivery model can help to reduce barriers to patient care.
Leadership
The vision of the AGA Committee for GI Innovation and Technology is to advance GI innovation aimed at reducing the burden of digestive diseases.
Simon Mathews, MD
Chair
WellSpan Digestive Health
Somaya Albhaisi, MBBCH, MD
Virginia Commonwealth University
Russ Arjal, MD, AGAF
Governing board liaison
WovenX Health
Bara El Kurdi, MD
Carilion Clinic/Virginia Tech Carilion School of Medicine
Samir C. Grover, MD, MEd
Scarborough Health Network/University of Toronto
Wendy Henderson, PhD
University of Pennsylvania
Sumant Inamdar, MD, MPH
University of Arkansas
Prasad G. Iyer, MD, AGAF
Mayo Clinic, Rochester
Christina Kratschmer, MD
Washington University
Aja McCutchen, MD
Atlanta Gastroenterology Associates
Jason B. Samarasena, MD, AGAF
University of California, Irvine
Eric Shah, MD, MBA
University of Michigan
Sidhartha R. Sinha, MD
Stanford University
Ali Soroush, MD, MS
Icahn School of Medicine at Mount Sinai
Mimi Tan, MD, MPH
Baylor College of Medicine
Vaibhav Wadhwa, MD
University of Texas McGovern Medical School, Houston
